These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4829529)

  • 1. Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.
    Hunter R; Thomson T; Reynolds CM; Pitcher PM
    J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):249-51. PubMed ID: 4829529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
    Schisano G; Franco A; Nina P; Papa ML; Iannuzzi M; De Biase R; Caldora M
    J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of cerebrospinal fluid protein electrophoresis].
    Neibrój-Dobosz I; Strumień M
    Neurol Neurochir Pol; 1970; 4(2):151-7. PubMed ID: 5447250
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):465-73. PubMed ID: 144927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism.
    Cade J; Hirsh J; Regoeczi E
    Blood; 1975 Apr; 45(4):563-8. PubMed ID: 1115842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinogen degradation products in the cerebrospinal fluid in central nervous system diseases].
    Kolanowska H; Solecka B
    Pol Przegl Chir; 1980 Aug; 52(8):729-34. PubMed ID: 7433284
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin-fibrinogen degradation products in cerebrospinal fluid.
    Brueton MJ; Breeze GR; Stuart J
    J Clin Pathol; 1976 Apr; 29(4):341-4. PubMed ID: 932226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrin fibrinogen degradation products in the cerebrospinal fluid of neurological patients].
    Nowak S; Zioło H; Błaszczyk B
    Neurol Neurochir Pol; 1984; 18(6):541-5. PubMed ID: 6100318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of CSF cytology in some neurological diseases.
    Appel E
    Rev Roum Neurol; 1973; 10(4):371-83. PubMed ID: 4767892
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
    Connaghan DG; Francis CW; Ryan DH; Marder VJ
    Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of fibrin degradation products and d-dimer levels as biomarkers that reflect the severity of trauma.
    Hagiwara S; Oshima K; Aoki M; Murata M; Ishihara K; Kaneko M; Furukawa K; Nakamura T; Ohyama Y; Tamura J
    J Trauma Acute Care Surg; 2013 May; 74(5):1275-8. PubMed ID: 23609278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FDP levels in the cerebrospinal fluid are elevated in patients with meningitis].
    Okamoto S; Takahashi H; Minoura K; Fujita N; Yoshimura M
    Rinsho Byori; 1991 Jun; 39(6):651-5. PubMed ID: 1880942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
    Bajo R; Vaca R; Elduayen R; Zarallo L; Cardesa JJ; Pérez-Miranda M
    Med Clin (Barc); 1980 Nov; 75(8):338-41. PubMed ID: 7442335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.
    Lee DH; Lee BK; Noh SM; Cho YS
    Eur J Trauma Emerg Surg; 2018 Apr; 44(2):291-298. PubMed ID: 28921171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.